pharmaphorum

NOVEMBER 3, 2022

Consumer and health organisations in the UK have written to the Trade Secretary Kemi Badenoch, saying a leaked chapter of the proposed UK-India free trade agreement (FTA) could raise the price of medicines used by the NHS. “India…supplies our NHS with 25% of all the medicines used to treat patients here in the UK,” they continue.

Medicine 85

Medicine Pharma Companies Sales Drugs 85

XTalks

JANUARY 20, 2025

While the deal required regulatory divestitures, including the sale of Otezla (apremilast) to Amgen for $13.4 This strategic move transformed Actavis into one of the largest pharma companies globally, with a strong presence across branded, generic and over-the-counter (OTC) medicines.

Marketing 104

Marketing Botox Life Science Pharma Companies 104

Pharmaceutical Technology

SEPTEMBER 2, 2022

Since the frontline treatment setting is dominated by these regimens, pharma companies have focused on the development of new drugs in the relapsed/refractory (R/R) setting. billion global sales expected by 2028, followed by Tecvayli with $2.6bn, which would mark a huge win for J&J in the MM space.

Antibody 147

Antibody Sales FDA Approval Production 147

pharmaphorum

JULY 14, 2022

Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 countries worldwide for testosterone deficiency and made sales of €117 million last year.

Drugs 97

Drugs Sales Pharma Companies Cardiology 97

World of DTC Marketing

JANUARY 24, 2022

Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? VCs invest money in biotech because they see a potential windfall via a profitable acquisition or sale, but when the FDA weighs in with delays, VCs can be ruthless. not necessarily.

Life Science 225

Life Science Drugs Development Genetic Disease 225

pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. The two drugs were developed by medical cannabis pioneer GW Pharma, which was acquired by Jazz last year.

Licensing 119

Licensing Licensing Marketing Medicine 119

Fossil Remedies

DECEMBER 29, 2022

There are many types of pharma businesses and one can choose any of them. Launching a pcd pharma company, for example, can be a way of reaping the benefit of pharma boom. If you are running a small business in this niche, then it is time for you to invest in any of the good pharma companies. Conclusion.

Pharma Companies 40

Pharma Companies Production Marketing Pharma Production 40

pharmaphorum

NOVEMBER 26, 2020

The new entity has been developed to service expansion within the prescription medicines market, the trend towards specialist and personalised therapies, and the surge in innovative health technologies. The post VMLY&R creates global healthcare agency for innovative pharma companies appeared first on.

Pharma Companies 52

Pharma Companies Marketing Development Branding 52

Camargo

NOVEMBER 11, 2020

In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. This is an increase in 14.2%

Marketing 100

Marketing Doctors Doctor Pharma Companies 100

pharmaphorum

MARCH 5, 2021

The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its blockbuster multiple sclerosis drug Copaxone. In the end it wasn’t enough and sales last year were $213 million, a fraction of the $4.3

Drugs 98

Drugs Sales Pharma Companies Generic Drugs 98

pharmaphorum

AUGUST 20, 2020

Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis drug Copaxone (glatiramer). The company will vigorously defend itself against these allegations.” and Teva Neuroscience Inc.

Generic Drugs 115

Generic Drugs Sales Pharmacy Pharma Companies 115

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS.

Marketing 119

Marketing Sales Pharma Companies Medicine 119

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen. When that happens, outcomes will change.

Pharma Companies 145

Pharma Companies Development Medicine Drugs 145

pharmaphorum

APRIL 12, 2022

Under the model, the NHS in England will pay a fixed annual fee for access to the two medicines of £10 million per year, calculated based on the value they offer the health service, regardless of how much is used to treat patients. Pfizer and Shionogi submitted the drugs for consideration in the scheme when it was first announced in 2019.

Pharma Companies 119

Pharma Companies Development Drugs Medicine 119

pharmaphorum

NOVEMBER 29, 2021

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. The facility was originally due to open in 2022, although the timeline slipped to 2023 before the UK government announced it was accelerating the timeline to next spring.

Vaccination 105

Vaccination Vaccine Manufacturing Pharma Companies 105

pharmaphorum

JANUARY 26, 2023

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time. It has drawn up the guidance with the help of the companies, the ABPI, and UK regulator the MHRA. .

Medicine 105

Medicine Pharma Companies Clinical Trials Clinical Trials 105

pharmaphorum

FEBRUARY 11, 2021

If pharma companies are to live up to their decades-old patient-centric promises then marketing budgets need to move from brands and franchises to omnichannel customer-centric teams, according to one digital transformation leader. Pharma companies really need to become patient, but also healthcare professional, centric.

Pharma Companies 104

Pharma Companies Marketing Branding Life Science 104

pharmaphorum

NOVEMBER 30, 2022

The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine? The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

MAY 3, 2022

The new drug – Quviviq (daridorexant) – has been approved by the European Commission for adults who have been suffering insomnia for at least three months and are experiencing “considerable impact” on daytime functioning, according to the Swiss pharma company.

Marketing 97

Marketing Drugs Sales Pharma Companies 97

World of DTC Marketing

JUNE 22, 2021

(New York Times ) If you spend any time reading pharma PR releases, you’ll see over and over again corporate managements stressing the importance of the shareholder. When a new drug is derailed the first thing that pops out is the effect on the company’s stock price, not patients. It is not for the profits.

Drugs 156

Drugs Medicine Pharma Companies Doctors 156

pharmaphorum

JANUARY 4, 2022

In 2019, drugs within the oncology therapeutic area accounted for $143 billion in branded pharmaceutical sales, equalling approximately 20% of all global pharmaceutical sales, according to McKinsey. This has led to a greater push into developing biologic medicine and exploring new ways to discover potential R&D candidates.

Pharma Companies 140

Pharma Companies Branding Development Sales 140

pharmaphorum

JUNE 23, 2021

Pharmaceutical sales and marketing operations have been forced to follow a steep learning curve as they adjust to operating within the rapidly evolving and hugely changed landscape caused by the pandemic. Physicians didn’t want to see sales reps that were just delivering useless messages, stated Edouard.

Life Science 102

Life Science Doctors Doctor Sales 102

pharmaphorum

DECEMBER 16, 2020

Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not just a nice-to-have for pharma companies – it’s a necessity for ensuring that patients have the best possible outcomes in modern healthcare systems.

Life Science 59

Life Science Pharma Companies Sales Medicine 59

pharmaphorum

OCTOBER 11, 2022

So, historically – certainly pre-2000 – if you look at the way prescription drugs were communicated, it was very tightly controlled: it was pharma companies speaking to doctors and the doctor would speak to the patient and tell them what they thought the right solution was,” he said.

Medicine 98

Medicine Pharma Companies Doctors Doctor 98

pharmaphorum

OCTOBER 7, 2021

The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug substance production through to full/finish and packaging, according to the company. According to the latest WHO data, just 4.4%

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

pharmaphorum

MAY 6, 2022

It has around 200 APIs in its portfolio, and also provides contract development and manufacturing services for more than 500 other pharma companies. Sanofi has retained a roughly 30% stake.

Marketing 64

Marketing Pharma Companies Sales Manufacturing 64

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. global growth for the year ahead.

Manufacturing 162

Manufacturing Marketing Production Drugs 162

pharmaphorum

FEBRUARY 4, 2021

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Epidiolex (cannabidiol) was the first cannabis-based medicine to be registered by the FDA in 2018, following that with a European approval (as Epidyolex) the following year.

Sales 64

Sales Medicine Marketing Pharma Companies 64

Pharma Marketing Network

JANUARY 29, 2025

With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. AI-powered chatbots, predictive modeling, and automated sales reps are reshaping HCP engagement and patient support. How does this impact pharma marketing?

Marketing 52

Marketing Compliance Big Data Branding 52

pharmaphorum

JANUARY 26, 2021

2020 was a psychological and systemic tipping point for telehealth, adoption of which will accelerate in 2021 as it becomes the norm, in the process driving new self-service approaches to medicine and participation-based reimbursement models. Mental health worsens – digital tools continue to fill the gap.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

pharmaphorum

NOVEMBER 22, 2022

Francis, who is currently CEO of gene therapy specialist Purespring Therapeutics and cardiovascular drug developer company Forcefield Therapeutics, is due to take the top job at Teva on 1 January, and will serve as the pharma company’s president.

Sales 59

Sales Gene Therapy Pharma Companies Gene 59

Pharma Marketing Network

FEBRUARY 10, 2022

Anton Yarovoy , Director of Precision Medicine and Lung at Novartis, agreed, saying, “Definitely, educational initiatives are becoming key at a time when [oncologists] keep getting a similar type of targeting. Sales reps’ interactions with oncologists have become less frequent due to pandemic-related restrictions.

Branding 98

Branding Marketing Life Science Pharma Companies 98

pharmaphorum

DECEMBER 7, 2020

Having worked all around the world to supply medicines to developing markets, Dr Zulf Masters understands the biggest barrier for a pharma company entering these regions is a lack of understanding of their complexities. The post Latin America: How pharma can navigate a complex market appeared first on.

Marketing 109

Marketing Regulation Production Medicine 109

Pharma Marketing Network

DECEMBER 31, 2024

Pharma marketing executives face unique challenges like regulatory restrictions, stiff competition, and shifting consumer expectations. So, how can you build trust, boost brand awareness, and still drive sales? Why is digital marketing crucial for pharma companies? How do branded drug campaigns boost marketing success?

Marketing 52

Marketing Branding Compliance Drugs 52

Creogenic Pharma

APRIL 15, 2023

Contact us at +918264379214 or drop an email at sales@creogenicpharma.com to know more about the available locations and the benefits of joining Creogenic Pharma. If you’re interested in setting up your own business in the pharma sector in Madhya Pradesh, get in touch with Creogenic Pharma today.

Pharma Companies 40

Pharma Companies Pharma Production Medicine Production 40

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. global growth for the year ahead.

Manufacturing 130

Manufacturing Production Marketing Drugs 130